Pular para o conteúdo
Merck

A protocol for the differentiation of human embryonic stem cells into midbrain dopaminergic neurons.

STAR protocols (2023-06-13)
Kaneyasu Nishimura, Emilía Sif Ásgrímsdóttir, Shanzheng Yang, Ernest Arenas
RESUMO

Here, we present a protocol for the generation of functional midbrain dopaminergic (mDA) neurons from human embryonic stem cells (hESCs), which mimics the development of the human ventral midbrain. We describe steps for hESC proliferation, induction of mDA progenitors, freezing stocks of mDA progenitors as an intermediate starting point to reduce the time to make mDA neurons, and maturation of mDA neurons. The entire protocol is feeder-free and uses chemically defined materials. For complete details on the use and execution of this protocol, please refer to Nishimura et al. (2023).1.

MATERIAIS
Número do produto
Marca
Descrição do produto

Sigma-Aldrich
3′,5′-monofosfato cíclico de N6,2′-O-dibutiriladenosina, ≥96% (HPLC), powder
Sigma-Aldrich
CHIR99021, ≥98% (HPLC)
Sigma-Aldrich
Anticorpo antitirosina hidroxilase, Chemicon®, from rabbit
Sigma-Aldrich
DAPT, ≥98% (HPLC), solid
Sigma-Aldrich
Anticorpo antiSox2, Chemicon®, from rabbit
Sigma-Aldrich
SU-5402, ≥98% (HPLC)
Sigma-Aldrich
PD 0325901, ≥98% (HPLC)
Sigma-Aldrich
GW3965 hydrochloride, ≥98% (HPLC), powder
Sigma-Aldrich
Anticorpo anti-LMX-1, serum, from rabbit